<DOC>
	<DOCNO>NCT02231268</DOCNO>
	<brief_summary>- Evaluation 6-months treatment Gladem - Experiences internet perform postmarketing study ( PMS ) trial</brief_summary>
	<brief_title>Observational Study Assess 6-months Treatment With Gladem</brief_title>
	<detailed_description />
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Sertraline</mesh_term>
	<criteria>Men woman least 18 year old De novo prescription Gladem Treatment Gladem intend least 6 month Depressive disorder Known hypersensitivity sertraline Concomitant treatment monoamine oxidase ( MAO ) inhibitor , selegiline , moclobemide ( washout least 14 day necessary ) Concomitant treatment serotoninergic substance like tryptophan fenfluramine Instable epilepsy According product information ( October 1998 ) Gladem prescription possible precaution follow case : Patients stable epilepsy Patients restrict liver function Suicidal patient Patients emotional state mark sleep disorder According product information ( October 1998 ) Gladem prescribed pregnancy lactation period , expect benefit great risk . Women childbearing age use Gladem combination sufficient contraception .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>